Spectrum Library

A review of human diseases caused or exacerbated by aberrant complement activation.

Publication Date April 2017

Microarray Analysis of lncRNA and mRNA Expression Profiles in Patients with Neuromyelitis Optica.

Publication Date April 2017

Rituximab in Neuromyelitis Optica Spectrum Disorders: Why Not as First-Line Therapy.

Publication Date April 2017

Rituximab in Neuromyelitis Optica Spectrum Disorders: Why Not as First-Line Therapy.

Publication Date April 2017

Rituximab in Neuromyelitis Optica Spectrum Disorders-Reply: Why Not as First-Line Therapy.

Publication Date April 2017

Learn More

Normal-appearing white matter demyelination in neuromyelitis optica spectrum disorder.

Publication Date April 2017

Optic Neuropathy Associated with Primary Sjögren’s Syndrome: A Case Series.

Publication Date April 2017

Neuromyelitis Spectrum Disorders.

Publication Date April 2017

Bell’s palsy in children: Current treatment patterns in Australia and New Zealand. A PREDICT study.

Publication Date April 2017

Large-Scale in-House Cell-Based Assay for Evaluating the Serostatus in Patients with Neuromyelitis Optica Spectrum Disorder Based on New Diagnostic Criteria.

Publication Date April 2017

Anti-NMDAR encephalitis followed by seropositive neuromyelitis optica spectrum disorder: A case report and literature review.

Publication Date April 2017

Elevated C-X-C motif ligand 13 and B-cell-activating factor levels in neuromyelitis optica during remission.

Publication Date April 2017

Previous
1
2
3
4
…
74
Next